Pitavastatin calcium composition
A technology of pitavastatin calcium and a composition is applied in the field of preparation compositions containing pitavastatin calcium tablets, and can solve the problems of uneven content between tablets, low dissolution rate of pitavastatin calcium tablets, etc.
Inactive Publication Date: 2016-01-06
DISHA PHARMA GRP
View PDF4 Cites 1 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
[0005] The purpose of the present invention is to solve the problem of low dissolution rate of pita
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreExamples
Experimental program
Comparison scheme
Effect test
Login to View More
PUM
Login to View More
Abstract
The invention relates to a preparation composition containing pitavastatin calcium tablets, and belongs to the technical field of medicines. The technical scheme is that 1000 tablets of the preparation composition comprise 1-2 g of pitavastatin calcium of which the D90 is 25 [mu]m, 30-70 g of lactose, 10-60 g of microcrystalline cellulose, 8-15 g of mannitol, 3.0-16 g of low substituted hydroxypropyl cellulose, 0.15-0.5 g of sodium carboxymethyl cellulose and 0.5-1.0 g of magnesium stearate. According to the technical scheme, through the addition of mannitol and reasonable control of the granularity, the problems of relatively low dissolvability and nonuniform content of the tablets are solved.
Description
technical field [0001] The invention relates to a preparation composition containing pitavastatin calcium tablets, belonging to the technical field of medicine. Background technique [0002] Pitavastatin Calcium Tablets is a third-generation statin drug jointly developed by Nissan Chemical Industry Co., Ltd. and Kowa Co., Ltd. It was registered in Japan in November 1999 and was first approved for marketing in Japan on July 17, 2003. . It is mainly applicable to the treatment of hyperlipidemia and familial hypercholesterolemia. [0003] Pitavastatin calcium is insoluble in water, so pitavastatin calcium tablets have problems of low stability and dissolution rate. Using the prescription and preparation process involved in this article can effectively improve the stability of pitavastatin calcium and improve the dissolution rate, which is beneficial to Industrialized mass production. [0004] The commercial specifications of pitavastatin calcium are 1 mg and 2 mg. During the...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
IPC IPC(8): A61K9/20A61K31/47A61K47/26A61P3/06
Inventor 梁君付玉麦邹元华
Owner DISHA PHARMA GRP
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com